Clinical Trial Update: Synbiotic Therapy for NP-PASC [NA]

View source ↗

Summary

A completed clinical trial sponsored by Columbia University evaluating a synbiotic therapy for post-acute sequelae of SARS-CoV-2 infection (long COVID).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Synbiotic Therapy

Snippet

Sponsor: Columbia University | Conditions: Post-Acute COVID-19 Syndrome, Long COVID-19 | NA | Status: COMPLETED